Validation of a 46-gene Cell Cycle Progression (CCP) RNA Signature for Predicting Prostate Cancer Death
Peter T. Scardino, MD, FACSMemorial Sloan Kettering Cancer Center
Click HERE to read an exclusive report by a UroToday medical writer.
Click HERE to view the poster from this session.
Login to update email address, newsletter preferences and use bookmarks.